.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for inclusion of patients with MASLD as well as measurement of liver outcomes in cardio-- renal-- metabolic trials, when information recommend mechanistically tenable perks as well as professional security-- and also lays out considerations for trial concept as well as governing commendation.